A detailed history of Private Advisor Group, LLC transactions in Evogene Ltd. stock. As of the latest transaction made, Private Advisor Group, LLC holds 14,013 shares of EVGN stock, worth $35,873. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14,013
Previous 14,013 -0.0%
Holding current value
$35,873
Previous $10,000 10.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022

SELL
$1.63 - $2.83 $815 - $1,415
-500 Reduced 3.45%
14,013 $23,000
Q3 2021

Oct 14, 2021

BUY
$2.45 - $3.45 $2,450 - $3,450
1,000 Added 7.4%
14,513 $38,000
Q2 2021

Aug 12, 2021

BUY
$3.3 - $5.02 $4,950 - $7,529
1,500 Added 12.49%
13,513 $46,000
Q1 2021

Apr 22, 2021

BUY
$4.29 - $9.94 $51,535 - $119,409
12,013 New
12,013 $61,000

Others Institutions Holding EVGN

About Evogene Ltd.


  • Ticker EVGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,202,000
  • Market Cap $105M
  • Description
  • Evogene Ltd., together with its subsidiaries, operates as a computational biology company. It focuses on product discovery and development in multiple life-science based industries, including human health and agriculture, through the use of its Computational Predictive Biology (CPB) platform. The CPB platform, incorporating a deep understanding ...
More about EVGN
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.